跳至主要内容
临床试验/NL-OMON41465
NL-OMON41465已完成不适用

THE EFFECTS OF REAL-TIME CONTINUOUS GLUCOSE MONITORING ON GLYCEMIA AND QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS AND IMPAIRED HYPOGLYCEMIA AWARENESS - IN CONTRO

Vrije Universiteit Medisch Centrum0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Type 1 diabetic patients
  • - Use of multiple daily injections of insulin (with a basal insulin injection and bolus injections) or continuous subcutaneous insulin infusion
  • - Any HbA1c
  • - Age between 18 and 70 years old (inclusive)
  • - IHA according to the questionnaire by Gold et al. (Diabetes Care 17:697-703, 1994)
  • - Performing at least 3 SMBG/day or 21 SMBG/week

排除标准

  • - Type 2 diabetes mellitus
  • - History of (recent) major renal, liver, or (ischemic) heart disease (including cardiac conduction disorders)
  • - Current untreated unstable diabetic retinopathy
  • - Current (treatment for) malignancy
  • - Current use of non-selective beta-blockers
  • - Current psychiatric disorders, including schizophrenia, bipolar disorder, anorexia nervosa or bulimia nervosa
  • - Substance abuse or alcohol abuse (men >21 units/week, women >14 units/week)
  • - Current pregnancy or intention to conceive
  • - Current use of RT-CGM other than for short term (i.e. diagnostic use or use shorter than 3 consecutive months)
  • - Hearing or vision impairment hindering perceiving of glucose display and alarms, or otherwise incapable of using a (RT-)CGM, in the opinion of the investigator
  • - Poor commandment of the Dutch language or any (mental) disorder that precludes full understanding of the purpose and instructions of the study
  • - Participation in another clinical study
  • - Known or suspected allergy to trial product or related products

研究者

相似试验